Mark Christianson Neuroone Medical Technologies Corp (NMTC) insider trading activity

Mark Christianson is Business Development Director of NEUROONE MEDICAL TECHNOLOGIES Corp. Currently has a direct ownership of 271,491 shares of NMTC, which is worth approximately $168,324. The most recent transaction as insider was on Dec 26, 2023, when has been sold 6,848 shares (Common Stock) at a price of $1.35 per share, resulting in proceeds of $9,244. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 271K

6.94% 3M change

15.98% 12M change

Total Value Held $168,324

Mark Christianson Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 26 2023	SELL Open market or private sale	$9,244 $1.35 p/Share	6,848 Reduced 2.02%	332,039 Common Stock
Dec 22 2023	SELL Open market or private sale	$2,520 $1.4 p/Share	1,800 Reduced 0.53%	338,887 Common Stock
Dec 21 2023	SELL Open market or private sale	$13,869 $1.4 p/Share	9,907 Reduced 2.83%	340,687 Common Stock
Nov 30 2023	SELL Payment of exercise price or tax liability	$130 $1.45 p/Share	90 Reduced 0.03%	350,594 Common Stock
Nov 02 2023	SELL Payment of exercise price or tax liability	$144 $1.61 p/Share	90 Reduced 0.03%	350,684 Common Stock
Oct 31 2023	SELL Payment of exercise price or tax liability	$81 $0.9 p/Share	90 Reduced 0.03%	350,774 Common Stock
Sep 30 2023	SELL Payment of exercise price or tax liability	$80 $0.89 p/Share	90 Reduced 0.03%	350,864 Common Stock
Aug 31 2023	SELL Payment of exercise price or tax liability	$76 $0.85 p/Share	90 Reduced 0.03%	350,954 Common Stock
Jul 31 2023	SELL Payment of exercise price or tax liability	$91 $1.02 p/Share	90 Reduced 0.03%	351,044 Common Stock
Jun 30 2023	SELL Payment of exercise price or tax liability	$108 $1.2 p/Share	90 Reduced 0.03%	351,134 Common Stock
May 31 2023	SELL Payment of exercise price or tax liability	$108 $1.21 p/Share	90 Reduced 0.03%	351,224 Common Stock
Apr 30 2023	SELL Payment of exercise price or tax liability	$138 $1.54 p/Share	90 Reduced 0.03%	351,314 Common Stock
Apr 21 2023	BUY Grant, award, or other acquisition	-	14,000 Added 3.83%	351,404 Common Stock
Mar 31 2023	SELL Payment of exercise price or tax liability	$144 $1.61 p/Share	90 Reduced 0.03%	337,404 Common Stock
Mar 23 2023	SELL Open market or private sale	$19,066 $1.5 p/Share	12,711 Reduced 3.63%	337,494 Common Stock
Mar 22 2023	SELL Open market or private sale	$17,617 $1.51 p/Share	11,667 Reduced 3.22%	350,205 Common Stock
Mar 21 2023	SELL Open market or private sale	$3,395 $1.6 p/Share	2,122 Reduced 0.58%	361,872 Common Stock
Feb 03 2023	SELL Payment of exercise price or tax liability	$3,197 $1.47 p/Share	2,175 Reduced 0.59%	363,994 Common Stock
Feb 03 2022	BUY Grant, award, or other acquisition	-	15,000 Added 3.94%	366,169 Common Stock
Jun 24 2021	SELL Open market or private sale	$3,780 $6.3 p/Share	600 Reduced 0.06%	1,077,306 Common Stock
Jun 23 2021	SELL Open market or private sale	$76,162 $6.74 p/Share	11,300 Reduced 1.04%	1,077,906 Common Stock

Mark Christianson

Business Development Director

Eden Prairie, MN

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NMTC shares.

Notify only if

Value

Insider Trading

Get notified when an Neuroone Medical Technologies Corp insider buys or sells NMTC shares.

Notify only if

Operation

Value

Type

News

Receive news related to NEUROONE MEDICAL TECHNOLOGIES Corp

Track Activities on NMTC

Account